A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment.
| Author | |
|---|---|
| Abstract |
:
Doxylamine tablets are approved as an over-the-counter sleep aid. We developed a doxylamine succinate intranasal metered-dose delivery system with the expectation of a more rapid onset of action with reduced side-effect potential compared with the oral tablet. |
| Year of Publication |
:
2018
|
| Journal |
:
Drugs in R&D
|
| Volume |
:
18
|
| Issue |
:
2
|
| Number of Pages |
:
129-136
|
| ISSN Number |
:
1174-5886
|
| URL |
:
https://dx.doi.org/10.1007/s40268-018-0232-1
|
| DOI |
:
10.1007/s40268-018-0232-1
|
| Short Title |
:
Drugs R D
|
| Download citation |
